Cannabinoid Pharmacology

Franjo Grotenhermen, MD

Executive Director, International Association for Cannabinoid Medicines (IACM)

International Association for Cannabinoid Medicines · Rüthen, Germany

h-index 31

5,400+ citations

112+ publications

0 active trials

PubMed Profile ORCID Lab Website

Biography

Franjo Grotenhermen is a physician and the executive director of the International Association for Cannabinoid Medicines (IACM), one of the world's leading organizations dedicated to advancing cannabinoid medicine research and clinical practice. He has authored numerous books and scientific papers on cannabis pharmacology, clinical applications, and policy, and has been a central figure in the development of medical cannabis programs in Germany and internationally. Grotenhermen is known for his work on cannabis pharmacokinetics and the clinical management of cannabis-based medicines.

Key Contributions

1Founded and leads the IACM, advancing cannabinoid medicine internationally
2Published comprehensive reviews of cannabis pharmacokinetics and clinical pharmacology
3Contributed to the development of Germany's medical cannabis program
4Authored widely-used clinical guides for cannabis-based medicines
5Conducted research on THC blood levels and driving impairment

Selected Publications

Pharmacokinetics and pharmacodynamics of cannabinoids

1,243 citations

Clinical Pharmacokinetics · 2003

Comprehensive review of cannabinoid pharmacokinetics including absorption, distribution, metabolism, and elimination for THC, CBD, and other cannabinoids across multiple routes of administration.

DOI: 10.2165/00003088-200342040-00003

View all publications on PubMed